Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Accolade, Inc. ACCD
$10.55
-$0.2 (-1.86%)
На 18:02, 12 мая 2023
+83.70%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
795983540.00000000
-
week52high
17.01
-
week52low
5.07
-
Revenue
363142000
-
P/E TTM
-2
-
Beta
1.69101100
-
EPS
-5.63000000
-
Last Dividend
0.00000000
-
Next Earnings Date
28 июн 2023 г. в 10:59
Описание компании
Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| DA Davidson | Buy | 12 авг 2022 г. | |
| Wells Fargo | Equal-Weight | Equal-Weight | 05 июл 2022 г. |
| Goldman Sachs | Buy | Buy | 01 июл 2022 г. |
| Canaccord Genuity | Buy | Buy | 01 июл 2022 г. |
| Goldman Sachs | Buy | Buy | 26 мая 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 14 сент 2022 г. |
| Truist Securities | Buy | 07 сент 2022 г. | |
| Goldman Sachs | Buy | Buy | 21 сент 2022 г. |
| SVB Leerink | Market Perform | Market Perform | 07 окт 2022 г. |
| Goldman Sachs | Buy | Buy | 07 окт 2022 г. |
| Credit Suisse | Neutral | Neutral | 07 окт 2022 г. |
| Piper Sandler | Overweight | Overweight | 04 окт 2022 г. |
| Needham | Buy | Buy | 04 окт 2022 г. |
| Wells Fargo | Equal-Weight | Equal-Weight | 12 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
| Raymond James | Outperform | 02 февр 2023 г. | |
| Truist Securities | Buy | Buy | 30 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Barnes Stephen H. | D | 123237 | 138 | 18 янв 2023 г. |
| HILTON MICHAEL W | D | 129735 | 99 | 18 янв 2023 г. |
| Cavanaugh Robert N | D | 144796 | 176 | 18 янв 2023 г. |
| SINGH RAJEEV | D | 153865 | 276 | 18 янв 2023 г. |
| Barnes Stephen H. | D | 12024 | 415 | 17 янв 2023 г. |
| Barnes Stephen H. | A | 123375 | 415 | 17 янв 2023 г. |
| HILTON MICHAEL W | D | 9619 | 331 | 17 янв 2023 г. |
| HILTON MICHAEL W | A | 129834 | 331 | 17 янв 2023 г. |
| Cavanaugh Robert N | D | 14790 | 510 | 17 янв 2023 г. |
| Cavanaugh Robert N | A | 144972 | 510 | 17 янв 2023 г. |
Новостная лента
Why Shares of Accolade Soared This Week
The Motley Fool
13 янв 2023 г. в 12:39
Strong revenue growth and encouraging guidance pushed the stock up.
Accolade, Inc. (ACCD) Q3 2023 Earnings Call Transcript
Seeking Alpha
09 янв 2023 г. в 21:58
Accolade, Inc. (NASDAQ:ACCD ) Q3 2023 Earnings Conference Call January 9, 2023 4:30 PM ET Company Participants Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nundy - Chief Medical Officer Todd Friedman - Senior President of Investor Relations Conference Call Participants Michael Cherny - Bank of America Ryan Daniels - William Blair & Company Cindy Motz - Goldman Sachs Craig Hettenbach - Morgan Stanley Glen Santangelo - Jefferies Jonathan Yong - Credit Suisse William Hoover - Canaccord Genuity Jailendra Singh - Truist Ryan MacDonald - Needham Jessica Tassan - Piper Sandler. Stephanie Davis - SVB Securities Stanislav Berenshteyn - Wells Fargo Robert Simmons - D.A.
Accolade (ACCD) Reports Q3 Loss, Tops Revenue Estimates
Zacks Investment Research
09 янв 2023 г. в 18:48
Accolade (ACCD) delivered earnings and revenue surprises of 8.20% and 4.43%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Accolade to Announce Fiscal Third Quarter 2023 Financial Results
GlobeNewsWire
20 дек 2022 г. в 08:00
SEATTLE, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal third quarter 2023 financial results on Monday, January 9, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.
Accolade Inc. (ACCD) Q2 2023 Results - Earnings Call Transcript
Seeking Alpha
06 окт 2022 г. в 22:39
Accolade Inc. (NASDAQ:ACCD ) Q2 2023 Earnings Conference Call October 6, 2022 4:30 PM ET Company Participants Rajeev Singh - Chief Executive Officer Steve Barnes - Chief Financial Officer Shantanu Nundy - Chief Medical Officer Todd Friedman - Senior President of Investor Relations Conference Call Participants Michael Cherny - Bank of America Glen Santangelo - Jeffries Jonathan Yong - Credit Suisse Jailendra Singh - Truist Cindy Motz - Goldman Sachs Craig Hettenbach - Morgan Stanley Stephanie Davis - SVB Securities Richard Close - Canaccord Genuity. Stanislav Berenshteyn - Wells Fargo Dev Weerasuriya - Berenberg.